1. Home
  2. A-Z Index
  3. C list
  4. CA list
  5. CAT list
  6. CATA list

Catalyst Clinical Research Europe, Ltd., Macclesfield

Catalyst Clinical Research Europe, Ltd. is a private limited company. Once, it was named Aptus Clinical Limited (it was changed on 2023-04-27). Situated at Block 11, Suite 2, 2Nd Floor, Alderley Park, Macclesfield SK10 4TG, the above-mentioned 10 years old firm was incorporated on 2014-01-31 and is officially classified as "research and experimental development on biotechnology" (Standard Industrial Classification code: 72110).
2 directors can be found in this business: Nicholas D. (appointed on 29 April 2022), Patricia M. (appointed on 29 April 2022).
About
Name: Catalyst Clinical Research Europe, Ltd.
Number: 08872035
Incorporation date: 2014-01-31
End of financial year: 31 December
 
Address: Block 11, Suite 2, 2nd Floor
Alderley Park
Macclesfield
SK10 4TG
SIC code: 72110 - Research and experimental development on biotechnology
Company staff
People with significant control
Catalyst Clinical Research, Llc
29 April 2022 - 22 September 2022
Address 2528 Independence Blvd, Suite 100, Wilmington, Nc, 28412, United States
Legal authority Under The Laws Of The State Of North Carolina
Legal form Limited Liability Company
Country registered United States
Place registered Nc Secretary Of State
Registration number 1376420
Nature of control: significiant influence or control
75,01-100% shares
50,01-75% voting rights
Project Constellation Holdings, Inc.
29 April 2022 - 12 September 2022
Address 2528 Independence Blvd, Suite 100, Wilmington, Nc, 28412, United States
Legal authority Under The Laws Of The State Of North Carolina
Legal form Legal Corporation
Country registered United States
Place registered Nc Secretary Of State
Registration number 1763160
Nature of control: 25-50% voting rights
25-50% shares
Jonathan L.
6 April 2016 - 29 April 2022
Nature of control: 25-50% voting rights
25-50% shares
Stephen M.
6 April 2016 - 29 April 2022
Nature of control: 25-50% voting rights
25-50% shares
Financial data
Date of Accounts 2015-04-30 2016-04-30 2017-04-30 2018-04-30 2019-04-30 2020-04-30 2021-04-30 2022-04-28
Current Assets 351,279 614,083 1,171,583 1,016,115 1,176,854 1,568,248 1,915,500 1,356,888
Total Assets Less Current Liabilities 101,313 185,547 135,261 257,245 345,867 430,520 398,051 -441,199
Number Shares Allotted 1,000 1,000 - - - - - -
Shareholder Funds 101,313 185,547 - - - - - -
Tangible Fixed Assets - 7,898 - - - - - -

The target date for Catalyst Clinical Research Europe, Ltd. confirmation statement filing is 2024-02-04. The most recent one was submitted on 2023-01-21. The target date for a subsequent statutory accounts filing is 31 December 2023. Last accounts filing was sent for the time up until 28 April 2022.

4 persons of significant control are reported in the Companies House, namely: Catalyst Clinical Research, Llc owns over 3/4 of shares, over 1/2 to 3/4 of voting rights, has substantial control or influence. This corporate PSC is located at Independence Blvd, Suite 100, 28412 Wilmington, Nc. Project Constellation Holdings, Inc. owns 1/2 or less of shares, 1/2 or less of voting rights. This corporate PSC is located at Independence Blvd, Suite 100, 28412 Wilmington, Nc. Jonathan L. who owns 1/2 or less of shares, 1/2 or less of voting rights.

Company filing
Filter filings by category:
Accounts Address Annual return Capital Change of name Confirmation statement Incorporation Mortgage Officers Persons with significant control Resolution
Small-sized company accounts made up to 2022/12/31
filed on: 20th, December 2023 | accounts 		Free Download (10 pages)

Companies nearby - by postcode
Independence Exits Limited
Feel Gut Limited
Matrix Healthcare Group Limited
Evgen Limited
 
Project Orlando Bidco Limited
Project Orlando Topco Limited
Upskilla Limited